FISHFA BIOGENICS

Rajkot, India Founded: 2017 • Age: 9 yrs
Produces fermentation-based APIs for pharmaceuticals worldwide.

About FISHFA BIOGENICS

FISHFA BIOGENICS is a company based in Rajkot (India) founded in 2017. It operates as a B2B. FISHFA BIOGENICS offers products and services including Tacrolimus API, Cyclosporine API, Mupirocin API, and Mupirocin Calcium. FISHFA BIOGENICS operates in a competitive market with competitors including Ginkgo Bioworks, Kula Bio, Pivot Bio, Pluton Biosciences and BioConsortia, among others.

Key Metrics
  • Net Loss
    -₹20,330

    FY 2022 · 0% margin

  • EBITDA
    -₹5,330

    FY 2022 · 0% margin

Products & Services of FISHFA BIOGENICS

FISHFA BIOGENICS offers a comprehensive portfolio of products and services, including Tacrolimus API, Cyclosporine API, Mupirocin API, and Mupirocin Calcium.

Tacrolimus API
Immunosuppressant

Fermentation-based API for preventing organ transplant rejection.

Cyclosporine API
Immunosuppressant

API used in therapies to suppress immune responses.

Mupirocin API
Antibiotic

Fermentation-based API for treating bacterial infections.

Mupirocin Calcium
Antibiotic Derivative

API variant for enhanced bacterial infection treatment.

Apps and channels of FISHFA BIOGENICS

its YouTube channel Fishfa Biogenics has 109 subscribers and 1 videos.

Fishfa Biogenics
YouTube 109 subscribers 1 videos Business & Finance
Open channel

Videos from FISHFA BIOGENICS

The most watched videos on FISHFA BIOGENICS's YouTube channel, Fishfa Biogenics (109 subscribers). Click a video to play it here.

Fishfa Biogenics API
2.5K views

More on Fishfa Biogenics.

Board of directors of Fishfa Biogenics Limited (FISHFA BIOGENICS)

Fishfa Biogenics Limited is the primary company behind FISHFA BIOGENICS. The board of Fishfa Biogenics Limited currently have 3 directors; the longest-serving is Umang Kantilal Savani, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Umang Kantilal Savani
DIN 02952950
Director28 Mar 20197 yrs 6 moFishfa Biogenics Limited
Prashant Kanjibhai Kalavadia
DIN 02170444
Director28 Mar 20197 yrs 6 moFishfa Biogenics Limited
Pintu Kanjibhai Kalavadia
DIN 00385068
Director28 Mar 20197 yrs 6 moFishfa Biogenics Limited

People of FISHFA BIOGENICS

3 people are tracked at FISHFA BIOGENICS (2 in leadership, 1 in team).

NameRoleGroup
Jeet Zalavadia
CEOLeadership
Pravin Agrawal
Business Head- IndiaLeadership
Hetal Patel
Marketing In-chargeTeam
Premium access

Complete people profiles for FISHFA BIOGENICS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of FISHFA BIOGENICS

Figures of Fishfa Biogenics Limited, the primary company behind FISHFA BIOGENICS, for FY 2022. Net loss was -₹20,330 (0% margin). EBITDA was -₹5,330 (0% margin).

  • -₹20,330Net loss · 0% margin
  • -₹5,330EBITDA · 0% margin
  • ₹1.00 CrPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Fishfa Biogenics Limited are on its company page.

Premium access

Detailed financial statements for FISHFA BIOGENICS

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of FISHFA BIOGENICS

FISHFA BIOGENICS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ginkgo Bioworks, Kula Bio, Pivot Bio, Pluton Biosciences and BioConsortia, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ginkgobioworks.com2008Boston, United States$795.75M1,218
Gene editing-based cultured ingredients are provided for agriculture.
kulabio.com2018Natick, United States$71.23M12
Manufacturer of microbial crop nutrition products
pivotbio.com2010Berkeley, United States$618.08M256
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
plutonbio.com2017St. Louis, United States$24.18M15
Assay-based microbial research services are offered for industrial applications.
bioconsortia.com2014Davis, United States$56M–
Microbial biotech solutions for enhancing crop yields are developed.
newleafsym.com2011St. Louis, United States$181M35
Crop inputs are supplied using beneficial plant bacteria for agriculture.
agrospheres.com2016Charlottesville, United States$97.55M23
Manufacturer and supplier of biological agrochemicals
superbac.com.br1995Cotia, Brazil$62.59M–
Microbe-based fertilizers are provided for crop enhancement.
loambio.com2019Orange, Australia$119.5M–
Microbial seed coatings are developed for farming applications.
switchbioworks.com2022San Carlos, United States$26.88M–
Nitrogen-fixing fertilizers are developed from patented microbes.
Premium access

Detailed competitors of FISHFA BIOGENICS

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of FISHFA BIOGENICS

The website of FISHFA BIOGENICS (fishfabiogenics.com) receives about 1.7K visits a month.

  • Monthly visits
    1.7K

    ▲ 70.7% vs previous month

Similar companies to FISHFA BIOGENICS

10 companies that operate in the same segment as FISHFA BIOGENICS (Microbiome Therapeutics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Biosolutions and enzymes are developed for biotechnology applications across industries.
2000Bags Sword, Denmark–––
Pendulum is focused on developing advanced probiotic solutions.
2012San Francisco, California, United StatesUSD 109.5 M–55
Gut microbiome insights, analytics, tests, and therapeutics are provided.
2019Singapore, SingaporeUSD 10.5 MUSD 1.37 M–
Microbiome-based therapeutics for skin conditions like eczema are developed.
2014Farmington, United StatesUSD 37.4 M–12
Engineered microbes are developed as programmable therapeutics for metabolic disorders.
2013Cambridge, Massachusetts, United StatesUSD 34.4 MUSD 8 K1
Therapeutics for infectious and autoimmune diseases are developed.
2010Cambridge, Massachusetts, United StatesUSD 470.49 M–71
Biological drugs for skin and mucosa wound treatment are developed.
2016Uppsala, Uppsala County, SwedenUSD 4.02 MUSD 1.12 M–
Microbiome-based therapeutics for gut diseases are developed.
2017Edinburgh, Scotland, United KingdomUSD 72.96 M–65
The gut-brain axis is explored for therapeutic and nutritional innovations.
2014New York, New York, United StatesUSD 479 M–84
Microbiome therapeutics are developed to address diverse diseases.
2010Cambridge, Massachusetts, United StatesUSD 257.13 MUSD 789 K103
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about FISHFA BIOGENICS

FISHFA BIOGENICS was founded in 2017.

FISHFA BIOGENICS is headquartered in Rajkot, India. It is registered at Rajkot, Gujarat, India.

Fishfa Biogenics is a biopharmaceutical company based in Rajkot, India, specializing in manufacturing fermentation-based Active Pharmaceutical Ingredients like Tacrolimus and Cyclosporine. They focus on high-quality production for immunosuppressants, antibiotics, and antifungals, serving the global market through innovative processes and state-of-the-art facilities. The company emphasizes quality control and sustainability in its operations.

FISHFA BIOGENICS's top competitors include Ginkgo Bioworks, Pivot Bio and Kula Bio.

FISHFA BIOGENICS offers Tacrolimus API, Cyclosporine API, Mupirocin API, and Mupirocin Calcium.

FISHFA BIOGENICS operates through Fishfa Biogenics Limited.

The legal entities of FISHFA BIOGENICS currently have 3 directors, including Umang Kantilal Savani, Prashant Kanjibhai Kalavadia, Pintu Kanjibhai Kalavadia.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available